Reckitt Benckiser's surprise move for Mead Johnson Archives - Just Food
Join Our Newsletter - Get important industry news and analysis sent to your inbox – sign up to our e-Newsletter here
X

Reckitt Benckiser's surprise move for Mead Johnson

Why Reckitt Benckiser has moved for Mead Johnson – analysis

Why Reckitt Benckiser has moved for Mead Johnson – analysis

Mead Johnson has been the subject of takeover talk ever since it was spun-off from pharma group Bristol-Myers Squibb in 2009. Today's (10 February) news that the board of the US infant formula business has backed a potential sale came as little surprise - but what has raised eyebrows is the seemingly unlikely source of interest, UK condom-to-cleaning product provider Reckitt Benckiser. Katy Askew looks at the potential deal.

Why – as it stands – takeover of Mead Johnson is unlikely

Why – as it stands – takeover of Mead Johnson is unlikely

A new year, re-heated M&A speculation. Takeover talk is again centred on US-based infant formula group Mead Johnson, often seen as a target since it was spun off by pharma group Bristol-Myers Squibb in 2009. In the past, the chatter has focused on whether Danone would buy the Enfamil maker. Now, Nestle is in the spotlight. However, as Dean Best reports, such a deal looks unlikely - and, at present, the prospect of other suitors coming in appears just as slim.

Nestle mum on Mead Johnson takeover talk

Nestle has refused to comment on a report in the US claiming the world's largest food maker is considering a takeover offer for infant formula producer Mead Johnson. Financial news…

Mead Johnson lowers outlook despite China progress

Infant nutrition group Mead Johnson has lowered its full-year sales and earnings outlook despite noting progress has been made on lifting its sales trajectory in China.  Reporting its third-quarter results,…

Mead Johnson hails “improvement” despite Q1 declines

Mead Johnson, the US infant formula producer, today (28 April) claimed to be seeing progress in its performance despite reporting lower first-quarter sales and earnings. CEO Kasper Jakobsen said the Enfamil maker had…